Taken together, all these findings strongly support that autocrine BDNF/TrkB signaling contributes to tumor cell survival in CRC in vitro and in vivo. We also speculate that sortilin, as a transport protein as well as a potential pro-BDNF receptor, appears to be the key actor of this autocrine loop. This evidence concerns the gene NTRK2 and colorectal carcinoma.